Overexpression of Aldo-keto reductase family 1 B10 protein in ductal carcinoma in situ of the breast correlates with HER2 positivity

Cancer Biomarkers

Volumn 13, Issue 3, 2013, Pages 181-192

  Li, Zezhong ^a   He, Xin ^a   Xing, Shenyang ^a   Ni, Jinsong ^a   Zhang, Weihong ^a   Xu, Xiaofang ^a   Gao, Feng ^a   Gai, Jinhong ^a   Zhao, Zhihui ^a   Li, Jianhua ^a   Gong, Pengtao ^a   Zhang, Guocai ^a   Zhang, Xichen ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

AKR1B10; correlation; DCIS; HER2

Indexed keywords

ALDO KETO REDUCTASE FAMILY 1 B10 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ARTICLE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; ISOELECTRIC POINT; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ALDEHYDE REDUCTASE; BREAST NEOPLASMS; CARCINOGENESIS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; MICRODISSECTION; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL;

EID: 84881415055     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-130337     Document Type: Article

References (40)

1. R. A. Gatenby, K. Smallbone, P. K. Maini, F. Rose, J. Averill, R. B. Nagle and R. J. Gillies, Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer, Br J Cancer 97 (2007), 646-53. (Pubitemid 47339892)
2. D. Hanahan and R. A. Weinberg, Hallmarks of cancer: The next generation, Cell 144 (2011), 646-74.
3. R. Ali, W. Ma, F. Lemtiri-Chlieh, D. Tsaltas, Q. Leng, S. von Bodman and G. A. Berkowitz, Death don't have no mercy and neither does calcium: Arabidopsis cyclic nucleotide gated channel2 and innate immunity, Plant Cell 19 (2007), 1081-95. (Pubitemid 46953248)
4. H. J. Burstein, K. Polyak, J. S. Wong, S. C. Lester and C. M. Kaelin, Medical progress - Ductal carcinoma in situ of the breast, New England Journal of Medicine 350 (2004), 1430- 1441. (Pubitemid 38419997)
5. S. Nofech-Mozes, J. Spayne, E. Rakovitch and W. Hanna, Prognostic and predictive molecular markers in DCIS - A review, Advances in Anatomic Pathology 12 (2005), 256-264. (Pubitemid 41463806)
6. J. Lu, H. Guo, W. Treekitkarnmongkol, P. Li, J. Zhang, B. Shi and D. Yu, 14-3-3zeta cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition, Cancer Cell 16 (2009), 195-207.
7. S. K. Muthuswamy, D. Li, S. Lelievre, M. J. Bissell and J. S. Brugge, ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini, Nature Cell Biology 3 (2001), 785-92. (Pubitemid 32842683)
8. G. R. Wilson, A. Cramer, A. Welman, F. Knox, R. Swindell, H. Kawakatsu and N. J. Bundred, Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity, Br J Cancer 95 (2006), 1410- 4. (Pubitemid 44760094)
9. J. A.Menendez, L. Vellon, I. Mehmi, B. P. Oza, S. Ropero, R. Colomer and R. Lupu, Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells, Proc Natl Acad Sci USA 101 (2004), 10715-20. (Pubitemid 38955808)
10. R. C. Gehrau, D. S. D'Astolfo, C. I. Dumur, J. L. Bocco and N. P. Koritschoner, Nuclear expression of KLF6 tumor suppressor factor is highly associated with overexpression of ERBB2 oncoprotein in ductal breast carcinomas, PLoS One 5 (2010).
11. A. Negishi, M. Masuda, M. Ono, K. Honda, M. Shitashige, R. Satow and T. Yamada, Quantitative proteomics using formalin-fixed paraffin-embedded tissues of oral squamous cell carcinoma, Cancer Sci 100 (2009), 1605-11.
12. X. Zhang, S. S. Hashemi, M. Yousefi, J. Ni, Q. Wang, L. Gao and Y. G. Man, Aberrant c-erbB2 expression in cell clusters overlying focally disrupted breast myoepithelial cell layers: A trigger or sign for emergence of more aggressive cell clones? Int J Biol Sci 4 (2008), 259-69.
13. Y. G. Man, L. Tai, R. Barner, R. Vang, J. S. Saenger, K. M. Shekitka and B. L. Strauss, Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: Implications for tumor progression and invasion, Breast Cancer Res 5 (2003), R231-41.
14. J. H. Gai, P. T. Gong, J. H. Li, Y. G. Man, J. S. Ni, H. X. Ma and Y. Liu, Cell budding from pre-invasive tumors: Intrinsic precursor of invasive breast lesions? Exp Ther Med (2011), 633-639.
15. R. E. Roses, E. C. Paulson, A. Sharma, J. E. Schueller, H. Nisenbaum, S. Weinstein and B. J. Czerniecki, HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer, Cancer Epidemiol Biomarkers Prev 18 (2009), 1386-9.
16. D. Cao, S. T. Fan and S. S. Chung, Identification and characterization of a novel human aldose reductase-like gene, Journal of Biological Chemistry 273 (1998), 11429-35. (Pubitemid 28272034)
17. O. Gallego, F. X. Ruiz, A. Ardevol, M. Dominguez, R. Alvarez, A. R. de Lera and X. Pares, Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10, Proc Natl Acad Sci USA 104 (2007), 20764-9.
18. S. Heringlake, M. Hofdmann, A. Fiebeler, M. P. Manns, W. Schmiegel and A. Tannapfel, Identification and expression analysis of the aldo-ketoreductase1- B10 gene in primary malignant liver tumours, J Hepatol 52 (2010), 220-7.
19. Z. Scuric, S. C. Stain, W. F. Anderson and J. J. Hwang, New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma, Hepatology 27 (1998), 943- 50. (Pubitemid 28160478)
20. S. Fukumoto, N. Yamauchi, H. Moriguchi, Y. Hippo, A. Watanabe, J. Shibahara and H. Aburatani, Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas, Clinical Cancer Research 11 (2005), 1776-1785. (Pubitemid 40471839)
21. H. Yoshitake, M. Takahashi, H. Ishikawa, M. Nojima, H. Iwanari, A. Watanabe and Y. Araki, Aldo-keto reductase family 1, member B10 in uterine carcinomas: A potential risk factor of recurrence after surgical therapy in cervical cancer, International Journal of Gynecological Cancer 17 (2007), 1300- 1306. (Pubitemid 350077355)
22. J. Breton, M. C. Gage, A. W. Hay, J. N. Keen, C. P. Wild, C. Donnellan and L. J. Hardie, Proteomic screening of a cell line model of esophageal carcinogenesis identifies cathepsin D and aldo-keto reductase 1C2 and 1B10 dysregulation in Barrett's esophagus and esophageal adenocarcinoma, Journal of Proteome Research 7 (2008), 1953-1962.
23. J. Loeffler-Ragg, D. Mueller, G. Gamerith, T. Auer, S. Skvortsov, B. Sarg and H. Zwierzina, Proteomic identification of aldo-keto reductase AKR1B10 induction after treatment of colorectal cancer cells with the proteasome inhibitor bortezomib, Molecular Cancer Therapeutics 8 (2009), 1995-2006.
24. Z. J. Sahab, Y. G. Man, S. M. Semaan, R. G. Newcomer, S. W. Byers and Q. X. Sang, Alteration in protein expression in estrogen receptor alpha-negative human breast cancer tissues indicates a malignant and metastatic phenotype, Clin Exp Metastasis 27 (2010), 493-503.
25. G. P. Boland, I. S. Butt, R. Prasad, W. F. Knox and N. J. Bundred, COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ, British Journal of Cancer 90 (2004), 423-429. (Pubitemid 38250640)
26. S. Garcia, J. P. Dales, J. Jacquemier, E. Charafe-Jauffret, D. Birnbaum, L. Andrac-Meyer and C. Charpin-Taranger, c- Met overexpression in inflammatory breast carcinomas: Automated quantification on tissue microarrays, Br J Cancer 96 (2007), 329-35. (Pubitemid 46160639)
27. Y. C. Hwang, M. Kaneko, S. Bakr, H. Liao, Y. Lu, E. R. Lewis and R. Ramasamy, Central role for aldose reductase pathway in myocardial ischemic injury, Faseb Journal 18 (2004), 1192-9. (Pubitemid 39006881)
28. P. Velica, N. J. Davies, P. P. Rocha, H. Schrewe, J. P. Ride and C. M. Bunce, Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: Implications for modelling human cancers, Mol Cancer 8 (2009), 121.
29. Q. Ji, C. Aoyama, Y. D. Nien, P. I. Liu, P. K. Chen, L. Chang and A. Stolz, Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling, Cancer Research 64 (2004), 7610-7617. (Pubitemid 39372107)
30. C. Wang, R. Yan, D. Luo, K. Watabe, D. F. Liao and D. Cao, Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls, Journal of Biological Chemistry 284 (2009), 26742-8.
31. Y. Ye, Y. Xiao, W. Wang, K. Yearsley, J. X. Gao, B. Shetuni and S. H. Barsky, ER alpha signaling through slug regulates E-cadherin and EMT, Oncogene 29 (2010), 1451-1462.
32. A. Sadi, D. Y.Wang, B. J. Youngson, N. Miller, S. Boerner, S. J. Done andW. L. Leong, Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens, Bmc Cancer 11 (2011).
33. B. Crosas, D. J. Hyndman, O. Gallego, S. Martras, X. Pares, T. G. Flynn and J. Farres, Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: Consequences for retinoid metabolism, Biochemical Journal 373 (2003), 973-9. (Pubitemid 36981109)
34. C. S. Ross-Innes, R. Stark, K. A. Holmes, D. Schmidt, C. Spyrou, R. Russell and J. S. Carroll, Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer, Genes & Development 24 (2010), 171-182.
35. Y. Ye, Y. Xiao, W. Wang, K. Yearsley, J. X. Gao, B. Shetuni and S. H. Barsky, ERalpha signaling through slug regulates E-cadherin and EMT, Oncogene 29 (2010), 1451-62.
36. S. Fukumoto, N. Yamauchi, H. Moriguchi, Y. Hippo, A. Watanabe, J. Shibahara and H. Aburatani, Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas, Clinical Cancer Research 11 (2005), 1776-85. (Pubitemid 40471839)
37. C. Wang, R. L. Yan, D. X. Luo, K. Watabe, D. F. Liao and D. L. Cao, Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls, Journal of Biological Chemistry 284 (2009), 26742- 26748.
38. J. Ma, R. L. Yan, X. Zu, J. M. Cheng, K. Rao, D. F. Liao and D. L. Cao, Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells, Journal of Biological Chemistry 283 (2008), 3418-3423.
39. V. Iglesias-Guimarais, E. Gil-Guinon, G. Gabernet, M. Garcia-Belinchon, M. Sanchez-Osuna, E. Casanelles and V. J. Yuste, Apoptotic DNA degradation into oligonucleosomal fragments, but not apoptotic nuclear morphology, relies on a cytosolic pool of DFF40/CAD endonuclease, Journal of Biological Chemistry 287 (2012), 7766-79.
40. Z. Gang, H. Ting-lin, T. Chi, L. Zhan-peng, H. Wen-jie, H. Hong-da and L. Chen, Settling behaviour of pellet flocs in pelleting flocculation process: Analysis through operational conditions, Water Sci Technol 62 (2010), 1346-52.